Legacy Financial Strategies’s Thermo Fisher Scientific TMO Stock Holding History

Legacy Financial Strategies’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$278K	Sell	554 -44	-7%	-$21.1K	0.04%	125
2026 Q1	$294K	Buy	598 +15	+3%	+$8.14K	0.05%	114
2025 Q4	$338K	Buy	583 +8	+1%	+$4.52K	0.06%	96
2025 Q3	$279K	Buy	575 +36	+7%	+$16.8K	0.05%	112
2025 Q2	$219K	Buy	+539	New	+$225K	0.04%	119
2024 Q4	–	Sell	-380	Closed	-$235K	–	125
2024 Q3	$235K	Buy	380 +5	+1%	+$2.96K	0.05%	105
2024 Q2	$201K	Buy	+375	New	+$215K	0.05%	95

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Legacy Financial Strategies's TMO Position: Q2 2026 in Review

Legacy Financial Strategies reduced its Thermo Fisher Scientific (TMO) stake by 7.4% in Q2 2026, selling an estimated $21.1K and leaving 554 shares worth $278K. The position accounts for 0.04% of the portfolio, ranked #125.

Legacy Financial Strategies first reported a position in TMO in Q2 2024 and has held it in 7 quarters since. The position peaked at $338K in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Legacy Financial Strategies held 554 shares of Thermo Fisher Scientific worth $278K as of Q2 2026.
Legacy Financial Strategies sold 44 Thermo Fisher Scientific shares in Q2 2026, an estimated $21.1K.
Thermo Fisher Scientific made up 0.04% of Legacy Financial Strategies's portfolio in Q2 2026, its #125 holding.
Legacy Financial Strategies first reported a position in Thermo Fisher Scientific in Q2 2024 and has held it in 7 quarters since.
Legacy Financial Strategies's Thermo Fisher Scientific position peaked at $338K in Q4 2025.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Legacy Financial Strategies's 13F filing for Q2 2026, filed 21 Jul 2026.